Related Experiment Videos
Methimazole agranulocytosis treated with recombinant human granulocyte colony stimulating factor
M Moroni1, F Tommaselli, I Casagranda
1Istituto di Terapia Medica, Università, IRCCS Policlinico San Matteo, Pavia.
Recenti Progressi in Medicina
|June 1, 1995
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Nivolumab plus ipilimumab versus sunitinib for first-line treatment of advanced renal cell carcinoma: final analysis of efficacy and safety from the phase III CheckMate 214 trial.
Annals of oncology : official journal of the European Society for Medical Oncology·2026
ESMO adaptation of Lines of Systemic Therapy (EnLiST): a consensus framework for standardising the designation of lines of therapy in solid tumours.
Annals of oncology : official journal of the European Society for Medical Oncology·2026
Longitudinal validation of the PROFFIT questionnaire to assess financial toxicity in cancer patients.
Journal of cancer policy·2025
Final analysis of nivolumab plus cabozantinib for advanced renal cell carcinoma from the randomized phase III CheckMate 9ER trial.
Annals of oncology : official journal of the European Society for Medical Oncology·2025
[Efficacy of sacituzumab govitecan in multi-treated metastatic breast cancer and clinical management of oligoprogressions.]
Recenti progressi in medicina·2026
The struggle for a unified specialty in general practice, primary health care and community medicine in Italy.
Recenti progressi in medicina·2026
[A season of healthcare reforms?]
Recenti progressi in medicina·2026
Crocin as a multimodal therapy for multiple sclerosis: Recent breakthroughs in immunomodulation and neuroprotection.
Current journal of neurology·2026
SLC25A38 gene modification mediated by CRISPR/Cas9 in HEK293T cell line.
Journal of applied genetics·2026
Adipose-Derived Stem Cells in Ophthalmic Regenerative Medicine: From Cell Replacement to Precision Engineering.
Stem cell reviews and reports·2026
Application of Fibronectin-Coated Microparticles for Isolation of Human iPSC-Derived MSCs.
Tissue engineering and regenerative medicine·2026
Self-Amplifying RNA-Based Therapeutics: Advances, Challenges, and Future Perspectives.
Small (Weinheim an der Bergstrasse, Germany)·2026